Contact Us: 01282 426380
KM Financial Solutions | UPDATE 1-Roche says Tecentriq cocktail helps liver cancer patients live longer
56228
post-template-default,single,single-post,postid-56228,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

UPDATE 1-Roche says Tecentriq cocktail helps liver cancer patients live longer

21 Nov UPDATE 1-Roche says Tecentriq cocktail helps liver cancer patients live longer

Posted at 17:36h in News by
0 Likes
Swiss drugmaker Roche on
Friday said its immunotherapy Tecentriq combined with its
Avastin medicine helped people with the most common form of
liver cancer to live longer than with an older drug from
Germany’s Bayer.

No Comments

Sorry, the comment form is closed at this time.